Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [¹¹C]A-740003 as a novel tracer of neuroinflammation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of labelled compounds & radiopharmaceuticals

• Publication date

  2014-06-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jlcr.3206PMID 24995673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, radiolabeling and initial in vivo evaluation of [(11)C]KSM-01 for imaging PPAR-α receptors.

  2012cited by this paper
• Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo.

  2012cited by this paper
• Noninvasive molecular imaging of neuroinflammation

  2012cited by this paper
• Synthesis, in silico, in vitro, and in vivo investigation of 5-[¹¹C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2.

  2012cited by this paper
• Transition metals in organic synthesis. Part 101: Convergent total synthesis of 1,6-dioxygenated carbazole alkaloids

  2012cited by this paper
• Purinergic systems, neuropathic pain and the role of microglia.

  2012cited by this paper
• Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat

  2011cited by this paper
• The physiology, pharmacology and future of P2X7 as an analgesic drug target: hype or promise?

  2011cited by this paper
• P2X purinergic receptor ligands: recently patented compounds

  2010cited by this paper
• P2X7 Receptor Signaling Pathway as a Therapeutic Target for Neurodegenerative Diseases

  2010cited by this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cited by this paper
• Microglia: proliferation and activation driven by the P2X7 receptor.

  2010cited by this paper
• Synthesis and preclinical evaluation of novel PET probes for P-glycoprotein function and expression.

  2009cited by this paper
• Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.

  2009cited by this paper
• Synthesis and biological evaluation of (11)C-labeled beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging.

  2009cited by this paper
• Antagonists of the P2X(7) receptor. From lead identification to drug development.

  2009cited by this paper
• Synthesis and biological studies of inducible DNA cross-linking agents.

  2007cited by this paper
• A simple method for chemoselective phenol alkylation

  2007cited by this paper
• ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies.

  2007cited by this paper
• Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.

  2006cited by this paper
• BMC Neurology BioMed Central

  2006cited by this paper
• A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat

  2006cited by this paper
• Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors.

  2005cited by this paper
• An extremely stable and orthogonal DNA base pair with a simplified three-carbon backbone.

  2005cited by this paper
• Characterization with [3H]quisqualate of group I metabotropic glutamate receptor subtype in rat central and peripheral excitable tissues.

  2001cited by this paper
• Low-valent titanium : A new approach to deprotection of allyl and benzyl groups

  1992cited by this paper

• Longitudinal P2X7R and myelin PET reveal distinct neuroinflammatory and white matter signatures compared with TSPO PET and DTI-MRI in the TgF344-AD rat model

  2026cites this paper
• P2X7 receptors as targets for neuroprotection.

  2026cites this paper
• Imaging neuroglia.

  2025cites this paper
• P2RX7 modulates the function of human microglia-like cells and mediates the association of IL18 with Alzheimer’s disease traits

  2025cites this paper
• Radioligands Targeting the Purinergic P2X Receptors

  2025cites this paper
• Evaluation of [18F]F-PTTP as a Positron Emission Tomography Radioligand for Imaging P2X7 Receptors in Epileptic Rats.

  2025cites this paper
• PET imaging of neuroinflammation: any credible alternatives to TSPO yet?

  2024cites this paper
• IL-1RA Disrupts ATP Activation of P2RX7 in Human Monocyte-Derived Microglia-like Cells

  2024cites this paper
• Increased Cerebral Level of P2X7R in a Tauopathy Mouse Model by PET Using [18F]GSK1482160

  2024cites this paper
• Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?

  2023influential citation
• Leveraging the ATP‐P2X7 receptor signalling axis to alleviate traumatic CNS damage and related complications

  2023cites this paper
• Involvement of microglial P2X7 receptor in pain modulation

  2023cites this paper
• Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [18F]GSK1482160.

  2022cites this paper
• Recent advances in the development of antidepressants targeting the purinergic P2X7 receptor.

  2022cites this paper
• Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders

  2022cites this paper
• Agonists, Antagonists, and Modulators of P2X7 Receptors.

  2022cites this paper
• P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches

  2021influential citation
• Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology.

  2021cites this paper
• In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography.

  2021cites this paper
• Neuroinflammation as a Common Denominator of Complex Diseases (Cancer, Diabetes Type 2, and Neuropsychiatric Disorders)

  2021cites this paper
• The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.

  2021cites this paper
• PET Imaging of Neuroinflammation in Alzheimer’s Disease

  2021cites this paper
• Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain

  2021cites this paper
• Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer

  2021cites this paper
• Positron Emission Tomography in the Inflamed Cerebellum: Addressing Novel Targets among G Protein-Coupled Receptors and Immune Receptors

  2020cites this paper
• Radioligands targeting purinergic P2X7 receptor.

  2020cites this paper
• P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis

  2020cites this paper
• Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications

  2020cites this paper
• P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases

  2020cites this paper
• The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases

  2020cites this paper
• PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139

  2020cites this paper
• PET Imaging of Purinergic Receptors

  2020cites this paper
• Acute Microglial Responses to Single Non-Epileptogenic vs. Epileptogenic Seizures in Mouse Hippocampus

  2019cites this paper
• P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion

  2019cites this paper
• Synthesis and initial in vitro characterization of a new P2X7R radioligand [18F]IUR-1602.

  2019cites this paper
• Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.

  2019cites this paper
• Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development

  2019cites this paper
• PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation

  2019cites this paper
• The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment

  2019cites this paper
• P2X7 PET Radioligand 18F-PTTP for Differentiation of Lung Tumor from Inflammation

  2019cites this paper
• Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of 18F-JNJ-64413739, a PET Radioligand for P2X7 Receptors

  2019cites this paper
• [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers

  2019cites this paper
• Synthesis and in vitro biological evaluation of new P2X7R radioligands [11C]halo-GSK1482160 analogs.

  2019cites this paper
• Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.

  2019cites this paper
• Positron emission tomography imaging in evaluation of MS pathology in vivo

  2018cites this paper
• Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders

  2018cites this paper
• Synthesis and in vitro characterization of a P2X7 radioligand [123I]TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease

  2018cites this paper
• ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics.

  2018influential citation
• The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases.

  2018cites this paper
• In vivo PET imaging of neuroinflammation in Alzheimer’s disease

  2018cites this paper
• PET Imaging of Microglial Activation—Beyond Targeting TSPO

  2018cites this paper
• Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601.

  2018cites this paper
• Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation

  2018cites this paper
• PET Imaging in Psychoneuroimmunology Research.

  2018cites this paper
• Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders.

  2018cites this paper
• Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO

  2018cites this paper
• Molecular and Metabolic Imaging in Multiple Sclerosis.

  2017cites this paper
• Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7

  2017cites this paper
• Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations

  2017cites this paper
• Chapter 2 Imaging of neuroinflammation in Alzheimer ’ s disease , multiple sclerosis and stroke : recent developments in positron emission tomography

  2017cites this paper
• P2X7 receptor antagonists: a patent review (2010–2015)

  2017cites this paper
• Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis

  2017cites this paper
• Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks

  2017cites this paper
• Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery

  2017cites this paper
• Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response

  2017cites this paper
• Imaging of microglial activation in MS using PET: Research use and potential future clinical application

  2017cites this paper
• Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes

  2016cites this paper
• Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.

  2016cites this paper
• Novel MRI and PET markers of neuroinflammation in multiple sclerosis.

  2016cites this paper
• The microglial ATP‐gated ion channel P2X7 as a CNS drug target

  2016influential citation
• Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography.

  2016cites this paper
• Imaging neuroinflammation in Alzheimer’s and other dementias: recent advances and future directions

  2016cites this paper
• Preclinical Evaluation of a P2X7 Receptor–Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates

  2016cites this paper
• The evolution of P2X7 antagonists with a focus on CNS indications.

  2016cites this paper
• P2X ion channel receptors and inflammation

  2016cites this paper
• Role of neuro-immunological factors in the pathophysiology of mood disorders

  2016cites this paper
• Imaging neuroinflammation in multiple sclerosis using TSPO-PET

  2015cites this paper
• Translocator protein and new targets for neuroinflammation

  2015cites this paper
• Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions

  2015cites this paper
• Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.

  2015cites this paper
• Preliminary Clinical Experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT Imaging in Prostate Cancer Patients

  2014cites this paper
• Imaging neuroinflammation in Alzheimer’s disease and other dementias: Recent advances and future directions

  year unknowncites this paper